Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%

MT Newswires Live

03/03

Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.

SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.

The company's Kiwi shares rose 5% in recent Tuesday trade.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2616536454"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616536454\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616536454?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 05:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616536454","market":"sg","top_or_hot":-1,"title":"Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Partners With Singapore General Hospital to Offer Bladder Cancer Testing; Shares Up 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-03 05:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.</p><p>SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.</p><p>The company's Kiwi shares rose 5% in recent Tuesday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK8033","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2616536454","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616536454","pubTimestamp":1772488209,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  signed a service agreement with Singapore General Hospital , enabling clinicians to order Cxbladder Triage, TriagePlus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use TriagePlus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK8033":"生物科技","PEB.AU":"PACIFIC EDGE LTD","PEB.NZ":"Pacific Edge Limited Ordinary Shares","SGH.AU":"SGH Ltd","BK7120":"特殊消费者服务","BK7067":"生物科技","BK7031":"贸易公司与经销商"},"translate_title":"Pacific Edge与新加坡总医院合作提供膀胱癌检测；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGH.AU":1,"PEB.AU":1,"PEB.NZ":1.5},"content_text":"Pacific Edge (NZE:PEB, ASX:PEB) signed a service agreement with Singapore General Hospital (SGH), enabling clinicians to order Cxbladder Triage, Triage Plus, and Cxbladder Monitor from its Dunedin lab for hematuria patients and bladder cancer recurrence monitoring, according to a Tuesday filing with the Australian and New Zealand bourses.SGH will initially use Triage Plus, a urine-based genomic test analyzing both RNA and DNA, for microhematuria patients and Cxbladder Monitor for lower-risk non-muscle invasive bladder cancer patients, the filing added.The company's Kiwi shares rose 5% in recent Tuesday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}